NIRAMAI solution uses a high resolution thermal sensing device and a cloud hosted analytics solution for analysing the thermal images. Our SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in our solution have led to multiple US patents. Our novel algorithms have also been peer-reviewed in international scientific conferences.

Our cancer screening tool, SMILE, has been tested on 300 patients data from 2 hospitals and one diagnostic center. Early results from these tests indicate very high accuracy that is comparable and sometime better that Mammography. We have started 2 clinical trials with established hospitals to perform large scale, statistically significant clinical trials. We are working with multiple partners to make our solution commercially available by mid 2017.